Short answer
CareDx, Inc. (CDNA) filed an 8-K current report with the SEC on April 28, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.2). No earnings figures, reporting period, or operating metrics available in the provided text.
CareDx, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- No earnings figures, reporting period, or operating metrics available in the provided text
Item 7.01 · Regulation FD Disclosure
- Standard Regulation FD disclaimer language under Exchange Act Section 18
- Disclosure not automatically incorporated into Securities Act or Exchange Act filings
Item 8.01 · Other Events
- New $100 million share repurchase authorization, available for up to 24 months beginning April 30, 2026
- Authorization is incremental to the prior $50 million program approved in May 2025
- Repurchases funded from existing cash and future cash flow, reducing liquidity available for other uses
- Discretionary execution through open-market, negotiated transactions, or Rule 10b5-1 plans
- Program may be modified, suspended, or discontinued; no obligation to repurchase shares
Item EX-99.1 · Exhibit EX-99.2
- Q1 revenue $117.7M, up 39% year over year, led by Testing Services revenue growth of 48% to $91.4M
- GAAP net income $2.8M versus $10.4M loss, while adjusted EBITDA rose to $18.9M from $4.6M
- 2026 revenue guidance raised to $447M-$465M from $420M-$444M, signaling stronger growth expectations
- Lab Products divestiture agreed for $170M cash, sharpening focus on higher-margin Testing Services and Patient Solutions
- Board authorized up to $100M stock repurchases over 24 months, potentially supporting per-share value but reducing cash flexibility
Other items in this filing:
- Item 1.01: Entry into a Material Definitive Agreement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CareDx, Inc. 8-K filings
Get the next CDNA 8-K as it lands
Follow CDNA for push alerts, or ask the research agent what this filing means.